LivaNova PLC (LIVN) Price Target Increased to $89.00 by Analysts at Needham & Company LLC
LIVN has been the topic of a number of other reports. Berenberg Bank reiterated a buy rating and set a $70.00 target price on shares of LivaNova PLC in a research report on Friday, August 11th. Jefferies Group LLC lifted their target price on LivaNova PLC from $76.00 to $80.00 and gave the stock a buy rating in a research report on Friday, September 15th. Canaccord Genuity reiterated a hold rating and set a $71.00 target price on shares of LivaNova PLC in a research report on Wednesday, September 20th. BidaskClub cut LivaNova PLC from a buy rating to a hold rating in a research report on Tuesday, August 1st. Finally, Piper Jaffray Companies reiterated an overweight rating and set a $75.00 target price on shares of LivaNova PLC in a research report on Tuesday, September 12th. One analyst has rated the stock with a sell rating, three have issued a hold rating and five have issued a buy rating to the company’s stock. LivaNova PLC has a consensus rating of Hold and an average price target of $76.00.
LivaNova PLC (LIVN) traded up $3.68 during trading on Friday, reaching $81.76. The company’s stock had a trading volume of 781,883 shares, compared to its average volume of 402,811. The company has a debt-to-equity ratio of 0.04, a current ratio of 2.03 and a quick ratio of 1.36. The company has a market capitalization of $3,941.81, a price-to-earnings ratio of 23.56, a PEG ratio of 2.46 and a beta of 0.52.
LivaNova PLC (NASDAQ:LIVN) last posted its quarterly earnings results on Thursday, November 2nd. The company reported $0.93 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.76 by $0.17. LivaNova PLC had a return on equity of 9.33% and a net margin of 4.63%. The company had revenue of $309.70 million for the quarter, compared to analysts’ expectations of $301.22 million. During the same period last year, the firm earned $0.78 earnings per share. LivaNova PLC’s quarterly revenue was up 4.9% on a year-over-year basis. equities research analysts predict that LivaNova PLC will post 3.33 EPS for the current year.
TRADEMARK VIOLATION NOTICE: This news story was first published by Watch List News and is the property of of Watch List News. If you are viewing this news story on another publication, it was illegally stolen and republished in violation of U.S. & international copyright law. The legal version of this news story can be read at https://www.watchlistnews.com/livanova-plc-livn-price-target-increased-to-89-00-by-analysts-at-needham-company-llc/1681533.html.
In other news, Director Daniel Jeffrey Moore sold 1,000 shares of LivaNova PLC stock in a transaction dated Monday, October 16th. The stock was sold at an average price of $74.58, for a total transaction of $74,580.00. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Insiders have sold 3,000 shares of company stock worth $203,890 in the last quarter. Insiders own 0.28% of the company’s stock.
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Franklin Resources Inc. grew its holdings in shares of LivaNova PLC by 7.5% during the second quarter. Franklin Resources Inc. now owns 5,089,070 shares of the company’s stock worth $311,515,000 after buying an additional 354,956 shares during the last quarter. BlackRock Inc. grew its holdings in shares of LivaNova PLC by 79.3% during the second quarter. BlackRock Inc. now owns 4,648,780 shares of the company’s stock worth $284,552,000 after buying an additional 2,055,891 shares during the last quarter. State Street Corp grew its holdings in shares of LivaNova PLC by 74.8% during the second quarter. State Street Corp now owns 1,835,428 shares of the company’s stock worth $112,345,000 after buying an additional 785,268 shares during the last quarter. Koch Industries Inc. purchased a new position in shares of LivaNova PLC during the second quarter worth about $1,384,000. Finally, Dimensional Fund Advisors LP grew its holdings in shares of LivaNova PLC by 55.0% during the second quarter. Dimensional Fund Advisors LP now owns 922,229 shares of the company’s stock worth $56,450,000 after buying an additional 327,395 shares during the last quarter. 82.28% of the stock is currently owned by hedge funds and other institutional investors.
LivaNova PLC Company Profile
LivaNova PLC is a medical device company focused on the development and delivery of therapeutic solutions. The Company’s segments include Cardiac Surgery, Cardiac Rhythm Management, Neuromodulation and Other. The Cardiac Surgery segment is engaged in the development, production and sale of cardiovascular surgery products.
Receive News & Ratings for LivaNova PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LivaNova PLC and related companies with Analyst Ratings Network's FREE daily email newsletter.